These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37369876)

  • 1. Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis.
    Verde F; Milone I; Colombo E; Maranzano A; Dubini A; Colombrita C; Gentile F; Doretti A; Torre S; Messina S; Morelli C; Torresani E; Poletti B; Priori A; Maderna L; Ratti A; Silani V; Ticozzi N
    Neurol Sci; 2023 Oct; 44(10):3697-3702. PubMed ID: 37369876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis.
    Vacchiano V; Mastrangelo A; Zenesini C; Baiardi S; Avoni P; Polischi B; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol Neurosurg Psychiatry; 2023 Jun; 94(6):428-435. PubMed ID: 37012065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis.
    Cousins KAQ; Shaw LM; Shellikeri S; Dratch L; Rosario L; Elman LB; Quinn C; Amado DA; Wolk DA; Tropea TF; Chen-Plotkin A; Irwin DJ; Grossman M; Lee EB; Trojanowski JQ; McMillan CT
    Ann Neurol; 2022 Nov; 92(5):807-818. PubMed ID: 35877814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis.
    Maranzano A; Verde F; Dubini A; Torre S; Colombo E; Doretti A; Gentile F; Manini A; Milone I; Brusati A; Peverelli S; Santangelo S; Spinelli EG; Torresani E; Gentilini D; Messina S; Morelli C; Poletti B; Agosta F; Ratti A; Filippi M; Silani V; Ticozzi N
    Eur J Neurol; 2024 Sep; 31(9):e16374. PubMed ID: 38853763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach.
    Milella G; Zoccolella S; Giugno A; Filardi M; Urso D; Nigro S; Tafuri B; Tamburrino L; Gnoni V; Logroscino G
    J Neurol; 2023 Oct; 270(10):4868-4875. PubMed ID: 37338613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis.
    Verde F; Milone I; Colombo E; Maranzano A; Solca F; Torre S; Doretti A; Gentile F; Manini A; Bonetti R; Peverelli S; Messina S; Maderna L; Morelli C; Poletti B; Ratti A; Silani V; Ticozzi N
    Front Aging Neurosci; 2023; 15():1132808. PubMed ID: 37009451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of CSF NfL and tau in ALS.
    Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
    J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics.
    Kojima Y; Kasai T; Noto YI; Ohmichi T; Tatebe H; Kitaoji T; Tsuji Y; Kitani-Morii F; Shinomoto M; Allsop D; Teramukai S; Mizuno T; Tokuda T
    PLoS One; 2021; 16(11):e0260323. PubMed ID: 34843548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis.
    Lanznaster D; Hergesheimer RC; Bakkouche SE; Beltran S; Vourc'h P; Andres CR; Dufour-Rainfray D; Corcia P; Blasco H
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.
    Nakane S; Fujita K; Azuma S; Urushihara R; Kamada M; Harada M; Izumi Y; Kaji R
    Clin Neurol Neurosurg; 2018 Sep; 172():162-168. PubMed ID: 30016754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients.
    Verde F; Ferrari I; Maranzano A; Ciusani E; Torre S; Milone I; Colombo E; Doretti A; Peverelli S; Ratti A; Maderna L; Poletti B; Messina S; Morelli C; Silani V; Ticozzi N
    Neurol Sci; 2023 May; 44(5):1679-1685. PubMed ID: 36646859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyotrophic lateral sclerosis phenotypes significantly differ in terms of magnetic susceptibility properties of the precentral cortex.
    Conte G; Contarino VE; Casale S; Morelli C; Sbaraini S; Scola E; Trogu F; Siggillino S; Cinnante CM; Caschera L; Lo Russo FM; Triulzi FM; Silani V
    Eur Radiol; 2021 Jul; 31(7):5272-5280. PubMed ID: 33399906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis.
    Maranzano A; Verde F; Colombo E; Poletti B; Doretti A; Bonetti R; Gagliardi D; Meneri M; Maderna L; Messina S; Corti S; Morelli C; Silani V; Ticozzi N
    Brain; 2023 Oct; 146(10):4105-4116. PubMed ID: 37075222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis.
    Verde F; Milone I; Maranzano A; Colombo E; Torre S; Solca F; Doretti A; Gentile F; Manini A; Bonetti R; Peverelli S; Messina S; Maderna L; Morelli C; Poletti B; Ratti A; Silani V; Ticozzi N
    Ann Clin Transl Neurol; 2023 Jan; 10(1):118-129. PubMed ID: 36525477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Shi J; Qin X; Chang X; Wang H; Guo J; Zhang W
    J Cell Mol Med; 2022 Jan; 26(2):583-587. PubMed ID: 34866307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
    Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
    Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of serum versus plasma phospho-tau for Alzheimer's disease.
    Kac PR; Gonzalez-Ortiz F; Simrén J; Dewit N; Vanmechelen E; Zetterberg H; Blennow K; Ashton NJ; Karikari TK
    Alzheimers Res Ther; 2022 May; 14(1):65. PubMed ID: 35545792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.